Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 364 (RNA5SP364)

Target
RNA5SP364
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

**RNA, 5S ribosomal pseudogene 364 (RNA5SP364)** is annotated as a pseudogene related to the 5S ribosomal RNA (5S rRNA) gene[3]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements necessary for expression[2][3]. RNA5SP364 is classified as a non-coding RNA pseudogene, specifically an rRNA pseudogene, and does not encode a functional product nor participate in canonical ribosome structure or function[2][3]. There is no evidence that RNA5SP364 itself is a therapeutic target, disease-associated gene, biomarker, or involved in drug interactions. While some pseudogenes elsewhere in the genome have been studied for possible regulatory roles or association with disease processes, there is no literature or database evidence to suggest that RNA5SP364 itself has such functional or clinical significance[3][4][6]. **Note:** This entry is "incorrect" as a therapeutic target because RNA5SP364 is not a functional protein, receptor, enzyme, or druggable gene. It is a non-coding, non-functional genomic element without validated biological activity or therapeutic potential[3][2]. The name closely resembles that of true 5S ribosomal RNA; however, functional 5S rRNA (not a pseudogene) is a key part of the ribosome involved in protein synthesis[1][5]. In contrast, RNA5SP364 is a processed pseudogene, not a target[2][3].

Other names
RN5S364RNA, 5S ribosomal 364RNA5SP364

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 364 (RNA5SP364).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 364 (RNA5SP364).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call